Vironexis Biotherapeutics
Operator of a biotechnology form intended to offer AAV-delivered T-cell Immunotherapy. The company gene therapy platform enables the creation of off-the-shelf, single-dose gene therapies, enabling hea...
Valuation
$0
Share Price
N/A
Total Raised
$52M
Last Round
N/A